December 14-17, 2025
Marriott Marquis San Diego
Connect with Leaders in Oligonucleotide & Peptide Therapeutics
This is where the future comes to life, and these top companies are leading the way with cutting-edge technology, groundbreaking ideas, and bold visions. Whether you’re looking for fresh inspiration, potential partnerships, or the latest advancements, this list is your connection to the industry’s top innovators.
Visit their booths, explore their tech, and book meetings to connect with the leaders shaping what’s next.
Find where our sponsors are located on the show floor!
With more than 27 years of experience in the nucleic acid industry, Hongene is a specialist CDMO and raw materials supplier, committed to providing high-quality and high-value products and services with best-in-class lead times. Our world-leading manufacturing capacity of phosphoramidites is 58 tons and 54,000 liters for NTP per year, sufficient to support customers from small-scale to commercial production.
Visit Our Booth: 427
-
Tuesday, 11 November 2025 12:15 - 12:45 CET
Luncheon Spotlight Presentation 2
Chemoenzymatic Ligation: Advancing Next-Generation Manufacturing Technologies for siRNA and sgRNA
David Butler, PhD
Chief Technology Officer at Hongene Biotech Corporation
-
Wednesday, 12 November 2025 at 12:50 - 1:00 CET
TIDES Talks in Poster and Exhibit Hall
Modern Methodologies for the Design, Synthesis, Characterization, and Scale-Up of Novel Peptides
Balakumaran Kesavan, PhD
Group Leader – Analytical R&D, Small Molecules and Peptides CDMO at Aurigene Pharmaceutical Services
